Welcome to our dedicated page for Biolargo news (Ticker: BLGO), a resource for investors and traders seeking the latest updates and insights on Biolargo stock.
BioLargo, Inc. develops and commercializes sustainable technologies across cleantech, environmental engineering, water treatment and life sciences. Company updates commonly cover its Aqueous Electrostatic Concentrator, a PFAS treatment technology designed to remove and collect per- and polyfluoroalkyl substances from liquid streams, as well as engineering services and project work in water, wastewater, remediation and minerals processing.
BioLargo news also follows subsidiary activity, including Clyra Medical Technologies and its FDA-cleared wound care products based on Copper-Iodine Complex Technology, distribution partnerships for ViaCLYR, investor communications, annual operating results, and commercialization updates across medical, environmental and battery-related business lines.
BioLargo, Inc. (OTCQB:BLGO) will host an investor webcast and conference call on May 19, 2021, at 1:30 PM PT / 4:30 PM ET. The session aims to discuss the company's financial results and recent developments. The event is open to the public, with access to a replay available for later viewing. BioLargo specializes in developing sustainable technologies for environmental challenges, holding numerous patents, and operating through various subsidiaries. The webcast details and participation links are provided in the company’s investor relations section.
BioLargo, Inc. (OTCQB:BLGO) will present at the Benzinga Global Small Cap Conference on May 14, 2021, at 10:10 a.m. ET. The conference aims to connect small-cap companies with investors, focusing on cleantech advancements and growth prospects. CEO Dennis P. Calvert emphasizes BioLargo's dynamic business model, notably in PFAS remediation and water treatment. The event is free to attend, providing valuable insights into the company's innovative solutions. For registration, visit here.
BioLargo, Inc. (OTCQB:BLGO) has achieved a significant technical milestone with its Aqueous Electrostatic Concentrator (AEC), designed for treating PFAS-contaminated water. This development improves the AEC's electrical configuration, significantly reducing operating and maintenance costs. As a result, BioLargo can now finalize agreements for demonstration pilots and commercial trials. The AEC offers advantages over traditional PFAS filtration methods, with lower waste generation and reduced costs. The company is also enhancing its intellectual property related to the technology.
BioLargo, Inc. (OTCQB:BLGO) will present at the Benzinga Cleantech Small Cap Conference on April 22, 2021, at 11:20 AM EST. The company specializes in sustainable technologies and environmental engineering. CEO Dennis P. Calvert emphasized BioLargo's advancements in water remediation technologies, aimed at addressing critical global challenges. The conference focuses on clean technologies that promote eco-friendly practices.
Interested parties can sign up for the conference here.
BioLargo, Inc. (OTCQB:BLGO) filed its 2020 Annual Report with significant highlights. Revenue reached $2.43 million, a 31% increase from 2019, with fourth-quarter revenue of $900,000, up 36% from the previous quarter. The company reduced debt from $4.8 million to $1.7 million and announced the upcoming commercial launch of its PFAS water treatment solution. BioLargo continues to enhance its strategic partnerships and expand its technology offerings, positioning for future growth despite challenges from the COVID-19 pandemic.
BioLargo, Inc. (OTCQB:BLGO) announces a webcast and conference call on March 31, 2021, at 2 PM PST to discuss its 2020 financial results, releasing them after market close on March 30, 2021. The event will include a Q&A session open to the public. Interested participants can access the webcast on the company's Investor Relations page. BioLargo focuses on innovative environmental solutions and has secured over 80 grants to support its initiatives.
BioLargo, Inc. (OTCQB:BLGO) announced that CEO Dennis Calvert will present at the Q1 Virtual Investor Summit on March 25, 2021, at 1:30 PM ET. This event connects small- and mid-cap companies with investors. Calvert's presentation will showcase the company's sustainable technologies and their deployment across the country. BioLargo specializes in solving environmental challenges, holding numerous patents and grants. The summit features approximately 100 companies and aims to foster direct connections between companies and over 300 qualified investors.
BioLargo, Inc. (OTCQB:BLGO) has been invited to present its innovative AOS (Advanced Oxidation System) water treatment technology at Isle Utilities' iTAG event on March 4, 2021. Industry leaders from companies like Coca-Cola and Shell will participate in this event aimed at exploring sustainable water technologies. The AOS technology excels in efficient disinfection and removal of pharmaceutical micropollutants, making it valuable for various water treatment applications. This opportunity coincides with BioLargo's rollout of AOS through commercial trials at a poultry farm in Alberta, Canada.
BioLargo, Inc. (OTCQB:BLGO) announced it has eliminated $650,000 in debt, primarily due in August 2021. Remaining debts are manageable, with expectations for forgiveness on most SBA loans. This move aligns with reducing costly convertible debt and interest expenses. The company reported ongoing commercial milestones, including a new water treatment project expected to generate $500,000 in revenue and a $2 million project backlog. CEO Dennis P. Calvert emphasized their strong cash position and growth potential through innovative partnerships and technologies aimed at environmental challenges.
BioLargo, Inc. (OTCQB:BLGO) announced the acquisition of EcoMist®, a deodorizing and sanitizing technology, by its subsidiary ONM Environmental. This device installs on waste collection vehicles to spray odor control products during collection, aiming to enhance service for solid waste customers. EcoMist® is easy to install and complements ONM's existing CupriDyne Clean product. The acquisition requires a 10% royalty on sales, aligning with ONM's growth strategy in air quality control. EcoMist® is touted as a unique solution for odor and VOC management.